Progression of obesity-associated metabolic abnormalities can be reversed by immunotherapy, according to a new study published in Nature Medicine. Researchers from the University of Toronto and ...

Rhythm Pharmaceuticals (NASDAQ:RYTM) announced Monday that its lead asset, setmelanotide, reached the main goal in a pivotal ...